tiprankstipranks
Vor Bio price target lowered to $6 from $12 at JMP Securities
PremiumThe FlyVor Bio price target lowered to $6 from $12 at JMP Securities
2M ago
Vor Biopharma Secures $55.6M for Cancer Therapy Trials
Premium
Company Announcements
Vor Biopharma Secures $55.6M for Cancer Therapy Trials
2M ago
Vor Bio prices 55.87M shares at 99.425c in private placement
Premium
The Fly
Vor Bio prices 55.87M shares at 99.425c in private placement
2M ago
Vor Bio price target lowered to $14 from $22 at Baird
PremiumThe FlyVor Bio price target lowered to $14 from $22 at Baird
4M ago
Vor Biopharma Reports Q3 2024 Financial Results
Premium
Company Announcements
Vor Biopharma Reports Q3 2024 Financial Results
4M ago
Vor Bio reports Q3 EPS (40c), consensus (40c)
Premium
The Fly
Vor Bio reports Q3 EPS (40c), consensus (40c)
4M ago
Vor Bio announces new data,  plans to approach FDA on trial design by year-end
PremiumThe FlyVor Bio announces new data, plans to approach FDA on trial design by year-end
6M ago
Vor Bio price target lowered to $3 from $10 at Barclays
Premium
The Fly
Vor Bio price target lowered to $3 from $10 at Barclays
7M ago
Vor Bio reports Q2 EPS (41c) vs (45c) last year
Premium
The Fly
Vor Bio reports Q2 EPS (41c) vs (45c) last year
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100